Yılmaz, N.K. 2026. Dasatinib as a Repurposing Candidate for Alzheimer’s Disease: An Integrated In Silico Network Pharmacology and Molecular Docking Study. Trends in Pharmacy. 3, (Jun. 2026), 1–11. DOI:https://doi.org/10.5152/TIP.2026.26015.